Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
Article 2021 en
Authors
SM
Seyed Mojtaba Mousavi
MD
Maryam Derakhshan
FB
Fatereh Baharloii
Abstract
1 min read
Glioma, also known as glioblastoma multiforme (GBM), is the most prevalent and most lethal primary brain tumor in adults. Gliomas are highly invasive tumors with the highest death rate among all primary brain malignancies. Metastasis occurs as the tumor cells spread from the site of origin to another site in the brain. Metastasis is a multifactorial process, which depends on alterations in metabolism, genetic mutations, and the cancer microenvironment. During recent years, the scientific study of non-coding RNAs (ncRNAs) has led to new insight into the molecular mechanisms involved in glioma. Many studies have reported that ncRNAs play major roles in many biological procedures connected with the development and progression of glioma<b>.</b> Long ncRNAs (lncRNAs), microRNAs (miRNAs), and circular RNAs (circRNAs) are all types of ncRNAs, which are commonly dysregulated in GBM. Dysregulation of ncRNAs can facilitate the invasion and metastasis of glioma. The present review highlights some ncRNAs that have been associated with metastasis in GBM. miRNAs, circRNAs, and lncRNAs are discussed in detail with respect to their relevant signaling pathways involved in metastasis.
Ebrahim Balandeh, Kimia Mohammadshafie, Yaser Mahmoudi, Mohammad Hossein Pourhanifeh, Ali Rajabi, Zahra Razaghi Bahabadi, Amir Hossein Mohammadi, Neda Rahimian, Michael R Hamblin, Hamed Mirzaei
Mahmood Khaksary Mahabady, Sepideh Mirzaei, Hamidreza Saebfar, Mohammad Gholami, Amirhossein Zabolian, Kiavash Hushmandi, Farid Hashemi, Fatemeh Tajik, Mehrdad Hashemi, Alan Prem Kumar, Amir Reza Aref, Ali Zarrabi, Haroon Khan, Michael R Hamblin, Yavuz Nuri Ertaş, Saeed Samarghandian
Ali Rajabi, Mehrdad Kayedi, Shiva Rahimi, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Mina Homayoonfal, Seyed Mohammad Amin Mahdian, Michael R Hamblin, Omid Reza Tamtaji, Ali Afrasiabi, Ameneh Jafari, Hamed Mirzaei
Discussion(0)
No comments yet. Be the first to comment.